Scholar Rock Holding Corp:Apitegromab的CHMP意见预计将在Catalent印第安纳州工厂分类或第二设施纳入后出炉

美股速递
Jul 20

Scholar Rock Holding Corp 宣布,其候选药物Apitegromab的欧洲药品管理局人用药品委员会(CHMP)意见,预计将在其合同生产商Catalent的印第安纳州工厂完成分类评估,或被纳入第二个生产设施之后获得。这一进展是药物上市审批流程中的关键一步。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10